Objectives: The physiology of nearly all mammalian organisms are entrained by light and exhibit circadian rhythm. The data derived from animal studies show that light influences immunity, and these neurophysiologic pathways are maximally entrained by the blue spectrum. Here, we hypothesize that bright blue light reduces acute kidney injury by comparison with either bright red or standard, white fluorescent light in mice subjected to sepsis. To further translational relevance, we performed a pilot clinical trial of blue light therapy in human subjects with appendicitis. Design: Laboratory animal research, pilot human feasibility trial. Setting: University basic science laboratory and tertiary care hospital. Subjects: Male C57BL/6J mice, adult (> 17 yr) patients with acute appendicitis. Interventions: Mice underwent cecal ligation and puncture and were randomly assigned to a 24-hour photoperiod of bright blue, bright red, or ambient white fluorescent light. Subjects with appendicitis were randomized to receive postoperatively standard care or standard care plus high-illuminance blue light. Measurements and Main Results: Exposure to bright blue light enhanced bacterial clearance from the peritoneum, reduced bacteremia and systemic inflammation, and attenuated the degree of acute kidney injury. The mechanism involved an elevation in cholinergic tone that augmented tissue expression of the nuclear orphan receptor REV-ERBα and occurred independent of alterations in melatonin or corticosterone concentrations. Clinically, exposure to blue light after appendectomy was feasible and reduced serum interleukin-6 and interleukin-10 concentrations. Conclusions: Modifying the spectrum of light may offer therapeutic utility in sepsis. (Crit Care Med 2018; 46:e779-e787) 
V isible light (400-700 nm) modifies the capacity with which an organism responds to stress, and this physiology exhibits both circannual (seasonal) and diurnal (daily) variation (1) (2) (3) . For example, in response to the shorter photoperiod of the approaching winter, animals exhibit an enhancement in immune competence that improves the survival from sepsis (2, 4) . Even on a daily basis, there occurs a diurnal variation in circulating and tissue leukocyte concentrations that modifies the innate immunity (5-7). Thus, a paradigm emerges in which a circadian oscillation in immunity serves to bolster immune competence during periods of animal activity, when the probability of encountering microbial threat is elevated (5, 6, 8) . And, the dominant regulatory cue is light (6, (8) (9) (10) .
Light travels through a nonvisual optic pathway to the suprachiasmatic nucleus (SCN), where it serves as the primary environmental signal entraining an autonomous transcription-translation feedback loop comprised of a core set of genes: Clock, Bmal1, Period1-3 (Per), and Cryptochrome1-2 (Cry) (11) (12) (13) . A parallel pathway comprised of the nuclear receptor REV-ERBα also serves in a negative feedback loop to regulate Bmal1. Peripheral tissues also exhibit circadian oscillations in these clock genes (11) (12) (13) . These peripheral "clocks" have demonstrable roles in regulating immune cell function (14) (15) (16) (17) . In particular, REV-ERBα has been shown to link the macrophage (Mϕ) circadian clock to inflammatory function, including a selective and negative regulation of Mϕ cytokines, such as interleukin (IL)-6 and chemokine (C-C motif) ligand 2 (16, (18) (19) (20) . It is becoming apparent that many facets of immunity are regulated by individual components of this clock protein machinery, which are synchronized centrally by the SCN to temporally coordinate host physiology.
The central biological clock of the SCN possesses a 24-hour periodicity reflective of its dominant environmental cue, light, and it is the lower spectrum of "blue" light that maximally entrains this clock biology and circadian rhythms (21) (22) (23) (24) . We recently showed that high-illuminance, blue spectrum light can attenuate neutrophilic inflammation and organ injury in two murine models of warm ischemia/reperfusion (25) . Others have shown that fish exposed to green or blue light-emitting diodes (LEDs) during starvation exhibited less oxidative stress in comparison with those exposed to red LEDs (26) . These data suggest that the blue spectrum of light is a critical determinant of its biological effects. In this study, we turn our attention to sepsis. Using a clinically relevant murine model of intra-abdominal sepsis, we show that high-illuminance, blue spectrum light mediates adaptive changes in the immunity, in part through induction of tissue REV-ERBα, that protects against organ injury. We conduct a small pilot clinical trial in subjects with appendicitis to show clinical feasibility and to begin to explore biological relevance.
MATERIALS AND METHODS

Reagents
Antibodies for REV-ERBα (174309) and tubulin (ab4074) were obtained from Abcam (Cambridge, MA). The β 3 antagonist SR59230A (Sigma Aldrich, St. Louis, MO) was administered intraperitoneally at 5 mg/kg. Propranolol (Sigma Aldrich) was administered subcutaneously at 0.5 mg/kg. (-)-Nicotine (Sigma Aldrich) was administered intraperitoneally at 0.4 mg/kg. Alphabungarotoxin (Tocris Bioscience, Bristol, United Kingdom) was administered intraperitoneally at 1 µg/kg. The REV-ERBα agonist SR9009 (EMD Millipore, Billerica, MA) was dissolved in vehicle (15% Kollifor) and administered intraperitoneally at 100 mg/kg.
Animal Experimentation
We randomly assigned 8-12-week-old male C57BL/6J and Nr1d1 tm1Ven /LazJ (REV-ERBα ± heterozygous) (The Jackson Laboratory, Bar Harbor, ME) to a specific experiment. We performed cecal ligation and puncture as previously described (27) .
Mice were monitored using DSI HD-X11 implanted wireless telemetry (Data Sciences International, St. Paul, MN) as previously performed (28) . Data analysis was performed using Ponemah v5.20 (Data Sciences International).
For all studies, one investigator performed the surgical experimentation and collected the samples. An investigator blinded to the specific treatment then analyzed the data.
Exposure to Light
All experiments were conducted in a climatic room maintained on a day equals to night 12 hours:12 hours light:dark cycle (lights on from 08:00 to 20:00) at an ambient temperature of 21°C ± 2°C and a relative humidity of 60%. All experimentation was initiated at circadian time (CT) 2 (CT set 0 as previous dawn). Two Day-Light Classic DL930 light were used (Uplift Technologies, Dartmouth, NS) as previously described (25) . These lamps were fitted with blue (peak 442 nm) and red (peak 617 nm) filters (Lee Filters, Burbank, CA) and positioned over each cage to ensure identical illuminances of 1,400 lumens (25) . The heat emission modestly affects the cage temperatures (25°C ± 2°C) with no significant difference in the exposures of interest (25) .
Mice underwent CLP and then were randomly assigned to one of three lighting groups: red (617 nm, 1,400 lux), blue (442 nm, 1,400 lux), and ambient light (fluorescent white light, 400 lux) (25) . These lighting environments were administered for 24 hours immediately following experimentation.
Organ Physiology
Renal function was determined by assaying serum for Cystatin C, using an enzyme immunoassay kit (R&D, Minneapolis, MN). Cystatin C has emerged as a more precise marker of glomerular filtration rate (29) .
Immunoblot
Total tissue protein lysate was electrophoresed in a 15% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gel and developed as previously described (30) . Densitometry was performed by the NIH Image J64 program (National Institutes of Health, Bethesda, MD).
Cytokine Concentration
Tumor necrosis factor (TNF)-α, IL-6, and IL-10 concentrations were quantified using an enzyme-linked immunosorbent assay (ELISA) (R&D Systems) (27) .
Bacterial Culture
The peritoneal cavity was washed with 1 mL phosphate-buffered saline under sterile conditions. Peritoneal lavage and whole blood were subjected to 10-fold dilutions and cultured overnight in 5% sheep blood agar (Teknova, Hollister, CA). Colonyforming units were quantified by manual counting (31) .
Corticosterone Concentration
Serum corticosterone concentration was determined by ELISA (Enzo Life Science, Ann Arbor, MI) (25) .
Pilot Human Trial
Study Subjects. We conducted a pilot clinical trial between January 1, 2015, and December 1, 2015, in which we sought to determine the feasibility of applying high-illuminance blue spectrum lighting to subjects within the perioperative hospital setting and possessed the primary objective of successfully integrating the intervention into the delivery of perioperative care. This step was considered vital and prerequisite to embarking upon a larger clinical trial powered for clinical endpoints of interest. To achieve this end required an appreciation for the diverse interests/concerns of all involved stakeholders: nurses, physicians, and patients. Thus, we chose a subject population experiencing intra-abdominal sepsis but retaining cognitive and decision-making capacity:
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Protocol. Randomization was performed by computer generation of n equals to 20 treatment allocations. Treatment assignments were placed in sealed, opaque envelopes. Subjects assigned to blue light were fitted with blue filtered goggles (Lee Filters) and exposed to a Day × Light Classic Light for 18 hours beginning immediately postoperatively. The light was positioned on a stand with rolling casters, which enabled accurate positioning of the light in front of the subject regardless of the subject's location within the hospital (i.e., postoperative anesthesia care unit or inpatient room). Combined with the goggles, this intervention recapitulated the experimental conditions of our murine studies and ensure the transmission of a bright (1,400 lux) blue (peak 442 nm) light when the subject is within 12 inches. An investigator ensured appropriate light positioning and monitored compliance. The subjects assigned to the control group underwent usual care without any alterations of the ambient hospital lighting conditions. Endpoints. Our primary endpoint was feasibility as defined by successful administration of and compliance with the intervention of high-illuminance, blue spectrum lighting. Additional endpoints considered to be of translational relevance included serum concentrations of TNFα, IL-6, and IL-10 recorded at the time of admission preoperatively and approximately 18 hours postoperatively.
Statistics
Statistical analyses were performed using Stata 13SE software (College Station, TX). Continuous data were compared by t test. Wilcoxon rank-sum test was used for nonparametric data. Physiologic data were modeled using a fractional polynomial panel analysis. For the pilot trial, outcomes were evaluated on an intent-to-treat basis. An investigator blinded to the specific group allocations then analyzed the data. A p value of less than 0.05 was considered statistically significant.
Study Approval
We performed all animal experiments in accordance with the National Institutes of Health guidelines under protocols approved by the Institutional Animal Care and Use Committee of the University of Pittsburgh (16027633). The clinical trial was approved by the Institutional Review Board (PRO number 13080427). Written informed consent was obtained from all patients prior to inclusion in the study.
RESULTS
Blue Light Enhances Control of the Infection and Reduces Systemic Inflammation and Organ Injury During CLP Sepsis
Initially, we explored whether exposure to bright blue (BLUE), bright red (RED), or standard fluorescent, white light (AMBIENT) "after" sepsis altered immunity and control of the infection. We included an ambient fluorescent light exposure to replicate the typical indoor lighting environment (i.e., the hospital). As shown in Figure 1A , septic mice exposed to blue light exhibited a 60% reduction in bacterial burden within the peritoneal cavity, relative to either red or white light. Blue light also significantly reduced the magnitude of bacteremia (Fig.  1B) . This enhanced bacterial clearance was accompanied by attenuated systemic inflammation, as blue light reduced serum concentrations of TNFα, IL-6, and IL-10 by comparison with red or ambient light (Fig. 1 C-E) : BLUE versus RED versus AMBIENT: TNFα: 19.0 versus 56.5 pg/mL (p = 0.005) versus 68.5 pg/mL (p = 0.02), IL-6: 849 versus 1,555 pg/mL (p = 0.13) versus 1,732 pg/mL (p = 0.05), IL-10: 372 versus 2,696 pg/mL (p = 0.002) versus 2,736 pg/mL (p = 0.01). An exaggerated immune response is postulated to underlie the organ injury of sepsis, and TNFα is a key mediator in the pathogenesis of acute kidney injury (AKI). Therefore, we next explored whether or not blue light altered the risk of AKI (32) . As shown in Figure  1F , septic mice exposed to blue light experienced reduced AKI as evidenced by lower serum Cystatin C concentrations, by comparison with red and ambient light: BLUE 467 ng/mL versus RED 582 ng/mL (p = 0.03) and versus AMBIENT 564 ng/ mL (p = 0.06).
Blue Light Functions Through a Cholinergic Pathway to Attenuate Inflammation and Organ Injury During CLP
We were interested in understanding the physiologic mechanisms by which blue light exerted its effects. The mice we used are naturally deficient in melatonin (33, 34) , and we observed little differences in systemic corticosterone concentrations in blue, red, and ambient exposed mice ( Supplemental Fig. 1a , Supplemental Digital Content 1, http://links.lww.com/CCM/ D553). And finally, we observed no significant differences in animal activity, a validated surrogate marker of circadian rhythms (Supplemental Fig. 1b , Supplemental Digital Content 1, http://links.lww.com/CCM/D553) (35, 36) . Thus, in favorably modifying the biology of sepsis, blue light uses a pathway independent of the central circadian effectors melatonin and corticosteroids.
We next investigated whether or not blue light altered autonomic tone. We observed that septic mice exposed to blue light exhibited lower heart rates and an early reduction in low frequency/high frequency (LF/HF), suggesting a withdrawal of adrenergic tone (Fig. 2, A and B) . However, pharmacologic antagonism of the β 3 -adrenoreceptor (SR59230A) did not reduce systemic inflammation, and a broad β-adrenoreceptor antagonist (propranolol) only reduced IL-10 concentrations (Supplemental Fig. 2 , Supplemental Digital Content 2, http:// links.lww.com/CCM/D554). Reduced LF/HF may be due to elevated cholindergic tone, and mice exposed to blue light exhibited elevated high frequency (i.e., a variable of parasympathetic tone), by comparison with mice exposed to red light (Fig. 2C) . Repeating these experiments to determine the effects of modulating cholinergic tone on our prior endpoints of interest: serum cytokine concentration and tissue injury. We observed that blue light attenuated inflammation and AKI, but these effects were prevented with the nicotine acetylcholine receptor antagonist α-bungarotoxin (Fig. 2D) . The corollary was also observed; augmenting cholinergic tone with nicotine produced similar effects as blue light in reducing systemic inflammation (Fig. 2E) . Collectively, these data suggest that blue light augments cholinergic activity in attenuating the inflammation induced by CLP sepsis.
Blue Light Induces the Nuclear Receptor REV-ERBα in Reducing the Inflammation and Organ Injury of Sepsis
Diurnal variation in immune function is evident, and the molecular components of the clock machinery have been shown to modulate immunity (5, 6) . In particular, the orphan nuclear receptor REV-ERBα has been shown to attenuate Mϕ inflammatory cytokine production. Thus, we hypothesized that blue light mediates its effects through an induction of REV-ERBα and explored whether or not augmenting or inhibiting REV-ERBα altered the effects of blue light on the biology of sepsis (16, 19) . We observed that early after CLP (i.e., within 8 hr), blue light induced elevated expression of REV-ERBα in the spleens of septic mice (Fig. 3A) . The administration of the biochemical REV-ERBα agonist (SR9009) at an early time point (i.e., 4 hr) after CLP significantly reduced serum cytokine concentrations (Fig. 3B) . Cystatin C concentrations were also lower with SR9009, although this did not attain statistical significance. By contrast, heterozygous REV-ERBα ± mice subjected to CLP were no longer protected by blue light (Fig. 3C) . Critical Care Medicine www.ccmjournal.org
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And finally, the administration of nicotine rapidly induced elevated splenic expression of REV-ERBα (Fig. 3D) . Thus, one mechanism by which blue light protects in sepsis is by augmenting cholinergic tone and the expression of REV-ERBα.
Blue Light Reduces Serum Cytokine Concentrations in Humans With Appendicitis
We translated these observations into a pilot clinical feasibility trial of blue light therapy for appendicitis (Supplemental Table 1 , Supplemental Digital Content 3, http://links.lww.com/ CCM/D555). Compliance was 100% with the intervention of blue goggles. Blue light did appear to affect the human biological response to appendicitis (Fig. 4) . Eight of 10 subjects (90%) allocated to blue light exhibited reductions in IL-6 in comparison with four of 10 (40%) exposed to standard hospital lighting (p = 0.07); for IL-10, the proportions were nine of 10 (90%) versus four of 10 (50%), p value equals to 0.03. TNFα concentrations were beneath the lowest detectable concentration of the standard curve for all serum samples.
DISCUSSION
Our data support that light can acutely modify the biology of sepsis and specifically that the spectrum is a critical determinant of its effects. A short exposure to blue light attenuates organ injury when the treatment is started after the induction of bacterial peritonitis. The protection may be mediated by enhanced immunocompetence, as it appears that blue light accelerates clearance of the infection, thereby reducing the systemic elaboration of mediators, such as TNFα, considered causal in the After 24 hr of recovery, mice underwent CLP and were exposed to a 24-hr photoperiod of high-illuminance blue or red spectrum light and monitored for 24 hr. Heart rate (HR) was continuously monitored. Low frequency (LF)/high frequency (HF) ratio was calculated as a variable of sympathetic tone and LF as a variable of parasympathetic tone (57, 58) . Each point is a single measurement of a single mouse at a single timepoint. Lines and colored areas represent a fractional polynomial estimate of the mean ± 95% CI of each variable for each cohort of red (n = 8) and blue (n = 8) light-exposed mice. D, Mice underwent CLP and were randomized to receive α-bungarotoxin (tx) (1 μg/kg, intraperitoneally) or equivolume vehicle and then exposure to a 24-hr photoperiod of either highilluminance red or blue spectrum light. Serum was analyzed for tumor necrosis factor (TNF)-α, interleukin (IL)-6, IL-10, and Cystatin C concentrations (10 total mice per group for all three experiments combined), mean ± sem. E, Mice underwent CLP and then received either nicotine (1 mg/kg, intraperitoneally) or equivolume control. After 24 hr, serum was analyzed for TNFα, IL-6, IL-10, and Cystatin C concentrations (nine total mice per group for all three experiments combined), mean ± sem. BLUe denotes bright blue, ReD denotes bright red.
development of organ dysfunction, such as AKI (32) . An intervention of blue light therapy is feasible when delivered after surgery, a clinically relevant and readily achievable time point of administration. And although preliminary, our pilot clinical data suggest translational relevance to human biology. Thus, acute blue light exposure may offer therapeutic utility to target the infection, control systemic inflammation, and mitigate organ injury in clinical circumstances that do not permit pretreatment, such as sepsis (Supplementary Fig. 3 , Supplemental Digital Content 4, http://links.lww.com/CCM/D556).
One mechanism by which light may alter the response to sepsis is through photoimmunomodulation (1, 7, (37) (38) (39) (40) . We previously showed that blue light functioned through an intact optic pathway to reduce the tissue injury of ischemia/reperfusion (I/R). Although not specifically studied herein, we hold that the eye is the gateway by which blue light enhanced immunity during CLP sepsis. Nearly, every facet of immunity exhibits a circadian pattern and appears under the regulatory influence of light (6, 8, 10) . Immunologically, this manifests as an increase in chemoattractants, leukocyte trafficking, inflammatory cytokines, and phagocytic ability in the hours preceding the commencement of activity (5, 6, 17, 41, 42) . On a daily basis, light entrains a circadian oscillation in leukocyte emigration into tissues that alters the susceptibility to infectious insults. In the hours preceding the active phase, circulating Ly6C hi monocytes and tissue leukocyte populations peak, which correlate with enhanced Figure 3 . Blue light induces the nuclear receptor REV-ERBα in reducing the inflammation and organ injury of sepsis. A, Mice underwent CLP and were exposed to red, blue, or ambient light for 8 hr, at which timepoint organs were harvested. Tissue expression of REV-ERBα and tubulin was analyzed by immunoblot (four mice total in each group). Corresponding densitometry blots compare splenic REV-ERBα expression from septic mice exposed to red, blue, or ambient light. B, Mice underwent CLP and after 4 hr were administered SR9009 (5 mg/kg, intraperitoneally). After a total of 24 hr, serum was harvested and assayed for tumor necrosis factor (TNF)-α, interleukin (IL)-6, IL-10, and Cystatin C concentrations, mean ± sem (n = 8 mice per group). C, Wild type (WT) and heterozygous REV-ERBα ± mice underwent CLP and were exposed to either red or blue light for 24 hr, at which point serum was harvested and assayed for TNFα, IL-6, IL-10, and Cystatin C concentrations, mean ± sem (n = 7 mice per group). D, Mice were randomized to receive nicotine (0.4 or 2.0 mg/kg, intraperitoneally) or equivolume normal (0.9%) saline. After 8 hr, the organs were harvested, and the tissue expression of REV-ERBα and tubulin was analyzed by immunoblot (four mice total in each group). Corresponding densitometry blots compare splenic REV-ERBα expression from septic mice administered normal (0.9%) saline, nicotine (0.4 mg/kg), and nicotine (2.0 mg/kg). AMBIENT denotes standard fluorescent, white light, BLUE denotes bright blue, RED denotes bright red. KD = kilodaltons.
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Light travels through this optic pathway to regulate the central clock machinery of the SCN, which is particularly entrained by blue light (11, 13) . Cryptochromes, the photoactive pigments in the eye, are maximally activated by light of the lower (400-450 nm) blue spectrum, and mice lacking the Cryptochrome 2 gene exhibit a lower sensitivity to acute light induction of SCN clock proteins (23) . We believe this heightened sensitivity to blue spectrum underlies our prior observations in I/R and those herein of sepsis, that blue light, above equally bright red light or ambient white light, most profoundly alters mammalian biology.
The SCN clock keeps peripheral tissues in harmony via the pineal gland, the hypothalamus-pituitary-adrenal axis and the autonomic nervous system (ANS) and their respective hormones melatonin, glucocorticoids, and catecholamines (43) . The prototypical mediator of photoimmunomodulation is melatonin, although corticosteroid stress hormones also exhibit circadian rhythm and may influence immunity (6, 8, 10, 44) . However, neither of these systems appeared to be involved in our studies (25) . Rather, blue light engaged a cholinergic pathway to attenuate the inflammation of CLP sepsis. This mechanism differed from what we observed during I/R, in which blue light withdrew adrenergic tone to attenuate neutrophil influx and tissue injury (25) . A cholinergic anti-inflammatory pathway has been well characterized, in which systemic inflammation and tissue injury are attenuated by vagus nerve signaling (45, 46) . This pathway impinges upon the spleen, and our data suggest that blue light also alters splenic clock biology (see below). Whether a cholinergic pathway and/or the spleen mediate the observed enhanced control of the infection necessitates additional investigation, as do the contextual differences between sepsis and I/R in the ANS pathways engaged by blue light.
Peripheral tissues also possess this clock protein machinery, which regulates phenotypic function (11, 13, 14, 16, 47) . The cellular response to either ischemia or lipopolysaccharide is dependent upon the timing of the insult relative to this cycle and the expression of these proteins (8, 47, 48) . Bmal1 has been characterized as "anti-inflammatory," attenuating nuclear factor κ-light-chain-enhancer of activated B cells and IL-6 production in mice during endotoxemia (47) . We focused our experimental design on REV-ERBα, which can repress inflammatory Mϕ cytokine production (16, 18) . By repressing Mϕ IL-10, REV-ERBα augments phagolysosomal maturation and enhances microbicidal function against mycobacterium (49) (50) (51) . Thus, we hypothesized that an augmentation in Mϕ REV-ERBα would ideally explain our observation of enhanced bacterial clearance, yet reduced systemic inflammation, and this is what we observed. Whether REV-ERBα alters microbicidal (e.g., phagocytosis) function to enhance bacterial clearance remains to be determined, as do the specific REV-ERBα-dependent alterations in immune cell function that underlie reduced inflammation. Despite considerable evidence describing the ramifications of light on animal biology, human observational studies have failed to identify an association between light exposure and clinical outcomes (52) (53) (54) . However, light is complex, defined by the photoperiod, the illuminance, and the spectrum, and no study has fully incorporated this complexity of light into its study design. Once hospitalized, a patient is exposed to a very different illuminance, photoperiod, and spectrum. Illuminance degrades from an outside brightness exceeding 30,000 to less than 400 lux inside at the hospital bed (39, 55) . The photoperiod is perturbed by nearly continuous, low-level lighting, and the spectrum of fluorescent light deviates considerably from the rich in blue spectrum of natural light (38, 56) . We attempted to address these limitations by developing a clinical intervention that replicated the properties of the blue light used in our animal experimentation. Although preliminary, our pilot data suggest that this blue light can acutely modify human biology. However, much translational investigation remains in determining the relevance of blue light as a therapeutic modality for humans with sepsis. There are notable biological differences between nocturnal (i.e., mice) and diurnal (i.e., humans) subjects. We need to confirm that the specific clock biology mechanisms operant in vivo in our murine models are also induced in humans experiencing the many forms of sepsis (pneumonia, diverticulitis) that present for clinical care. Furthermore, we need to study a more "typical" septic cohort and more clinically relevant outcomes, such as organ injury.
Sepsis continues to remain a considerable healthcare burden. Evolution has developed a biological toolbox that underlies adaptive alterations in immunity to enhance our defense mechanisms at a time of greatest likelihood of exposure to this threat (3, 38, 40) . The emerging paradigm is that the time of day is critical to the nature of the immune response to sepsis and that light, is the principle regulatory cue. Our data suggest that blue light can be used therapeutically during sepsis to modulate these mechanisms to mitigate inflammation and organ injury. If light does impart therapeutic value, further investigation to determine the precise characteristics (illuminance, photoperiod, wavelength) will be critically important to optimize its potential clinical translation.
